PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.\', \'Department of Internal Medicine, National Yang-Ming University Hospital, Yilan, Taiwan, ROC.\', \'Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\', \'Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan, ROC.\', \'Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/JCMA.0000000000000338
?:doi
?:hasPublicationType
?:journal
  • Journal of the Chinese Medical Association : JCMA
is ?:pmid of
?:pmid
?:pmid
  • 32349031
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all